drugset / Trial / NCT01968018
A Study of Safety and Effectiveness of Ultracet in Patients With Chronic Cancer Pain
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the analgesic (painkiller) effectiveness and safety of combination of tramadol HCI (37.5 mg)/acetaminophen (325 mg) in the treatment of chronic cancer pain.
Timeline
- Start
- 2004-07
- Primary completion
- 2007-04
- Completion
- 2007-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Acetaminophen | Small molecule | 325 mg | — |
| Subject | Tramadol HCI | Unknown | 37.5 mg | — |